Keyword: Sanofi

Amgen lightens the mood in a new TV ad for cholesterol med Repatha even as Amgen continues a patent dispute and price drops for the drug.

Pharma’s reputation is holding steady with patient groups with an annual study finding 41% giving pharma good marks, similar to 43% the year before.

Paris-based Sanofi joined French businesses and wealthy families in donating to restore Notre Dame Cathedral after Monday's disastrous fire.

After a tough year in the competitive MS field, Sanofi’s Lemtrada could hardly afford another setback. But that’s exactly what it got.

After listening to some familiar back-and-forth between pharma and PBM executives, lawmakers issued one decree: Something's got to give.

Boehringer Ingelheim brings its two business units together in a new corporate campaign centered on the unique bond between patients and animals.

Sanofi is rolling out a subscription model to allow patients access to its insulins for $99 per month.

AstraZeneca’s Fasenra is already pressuring GlaxoSmithKline's Nucala in severe eosinophilic asthma, and new data could help set up a showdown between the two in another indication.

Sanofi, hit hard by pricing pressure, is once again bringing out the job-chopping ax.

Drugs by bicycle messenger? For Sanofi and new partner Rappi, the answer is yes. And they're looking at much more.